US Stock MarketDetailed Quotes

ITRM Iterum Therapeutics

Watchlist

1.0300
+0.0100+0.98%

Close Oct 16 16:00 ET

1.0477
+0.0177+1.72%

Post 20:01 ET

23.39MMarket Cap-517P/E (TTM)

Iterum Therapeutics Stock Forum

Meltyy

Oct 15 01:52

1 PDUFA & 1 AdCom left in October 🗓️

See FDA PDUFA update 👇
$Iterum Therapeutics (ITRM.US)$ : 🤔
⇨ Oral Sulopenem
‣ Uncomplicated Urinary Tract Infections
‣ PDUFA: 10/25/24
$Lexicon Pharmaceuticals (LXRX.US)$ : [Adcom] 🤔
⇨ ZYNQUISTA (sotagliflozin)
‣ Type 1 Diabetes
‣ Adcom: 10/31/24
📣 Last Week’s PDUFA Decisions:
$ZLDPF: CRL 10/8 ❌
⚠️ due to timing of a 3rd-party mfg. facility reinspection
⇨ Dasiglucagon
‣ Congenital Hyperinsulinism
‣ PDUFA: 10/08/24 (NDA)
$RRBHY: Approved 10/11 ✅
⇨ Itovebi™ (inavolis...

SkinnyChick

Sep 10 09:13

$Iterum Therapeutics (ITRM.US)$ the dip to buy

103622690 DK

Sep 10 07:23

$Iterum Therapeutics (ITRM.US)$ Iterum Therapeutics PLC - Potential to Be First Oral Penem Approved in U.S.

Trytosaveabit

Sep 10 06:42

I would say!

$Iterum Therapeutics (ITRM.US)$ Average .10 spread so far on a 1.00 ticker! Needs a bit more liquidity! Hehehe

Trytosaveabit

Sep 10 06:16

A bit more

$Iterum Therapeutics (ITRM.US)$ Iterum announced that a meeting of the FDA Antimicrobial Drugs Advisory Committee (AMDAC) took place on September 9, 2024 at which Iterum's new drug application (NDA) for sulopenem etzadroxil/probenecid (oral sulopenem) for the treatment of uncomplicated urinary tract infections (uUTI) in adult women was discussed.
"We are encouraged by the AMDAC's discussion which acknowledged oral sulopenem as an important treatment option for certain patients with uUTI...

Trytosaveabit

Sep 10 06:06

Update

$Iterum Therapeutics (ITRM.US)$ Nasdaq resumes quotes at 7:25AM est! and Trading resumes at 7:30AM est

Trytosaveabit

Sep 10 06:02

Update

$Iterum Therapeutics (ITRM.US)$ Reuters· 1 min ago
Iterum Therapeutics Provides Update on FDA Advisory Committee Discussion of Oral Sulopenem for the Treatment of Uuti in Adult Women! PDUFA scheduled for October 25, 2024

Meltyy

Sep 10 04:37

📅 FDA PDUFA & AdCom Update…

📣 ITRM AdCom 9/9 meeting ongoing 🚗
👀 stay tuned for updates on meeting outcomes
See 👇 for further info.
🚨 This Week’s AdCom:
$Iterum Therapeutics (ITRM.US)$ : Meeting ongoing 🤔
⇨ Sulopenem
‣ uUTI (Uncomplicated Urinary Tract Infection)
‣ AdCom: 9/9/24
🚨 Last Week’s PDUFAs:
$Travere Therapeutic (TVTX.US)$ : Approved 9/5 🎉
⇨ FILSPARI (Sparsentan)
‣ IgA nephropathy (IgAN)
‣ PDUFA: 9/5/24
$Avadel Pharmaceuticals (AVDL.US)$ : Awaiting decision 🤔
⇨ LUMRYZ (sodium oxybate)
‣...